6TJK

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TJK_EDO_BBB_1920	94%	94%	0.067	0.967	0.3	0.15	-	-	0	0	100%	1
6TJK_EDO_BBB_1905	94%	76%	0.075	0.972	0.67	0.28	-	-	1	0	100%	1
6TJK_EDO_BBB_1909	84%	92%	0.081	0.943	0.14	0.4	-	-	2	0	100%	1
6TJK_EDO_AAA_507	80%	89%	0.093	0.94	0.22	0.4	-	-	1	0	100%	1
6TJK_EDO_BBB_1910	76%	76%	0.077	0.911	0.38	0.55	-	-	0	0	100%	1
6TJK_EDO_AAA_506	75%	96%	0.12	0.953	0.11	0.25	-	-	0	0	100%	1
6TJK_EDO_AAA_508	75%	100%	0.102	0.934	0.08	0.09	-	-	0	0	100%	1
6TJK_EDO_AAA_516	74%	92%	0.123	0.953	0.14	0.39	-	-	0	0	100%	1
6TJK_EDO_AAA_520	73%	77%	0.104	0.931	0.45	0.47	-	-	1	0	100%	0.75
6TJK_EDO_BBB_1931	73%	81%	0.125	0.952	0.26	0.55	-	-	0	0	100%	1
6TJK_EDO_BBB_1911	71%	100%	0.113	0.932	0.06	0.1	-	-	0	0	100%	1
6TJK_EDO_BBB_1921	70%	94%	0.085	0.902	0.2	0.25	-	-	0	0	100%	1
6TJK_EDO_AAA_526	70%	98%	0.091	0.907	0.2	0.07	-	-	0	0	100%	1
6TJK_EDO_BBB_1922	69%	98%	0.106	0.92	0.15	0.1	-	-	0	0	100%	1
6TJK_EDO_AAA_512	68%	99%	0.108	0.919	0.02	0.19	-	-	0	0	100%	1
6TJK_EDO_AAA_525	67%	98%	0.128	0.936	0.08	0.17	-	-	0	0	100%	0.5
6TJK_EDO_BBB_1915	63%	64%	0.13	0.925	0.73	0.65	-	-	4	0	100%	1
6TJK_EDO_BBB_1913	62%	96%	0.134	0.926	0.11	0.25	-	-	0	0	100%	0.5
6TJK_EDO_BBB_1916	60%	88%	0.098	0.882	0.24	0.42	-	-	0	0	100%	1
6TJK_EDO_AAA_522	59%	94%	0.102	0.884	0.15	0.28	-	-	0	0	100%	1
6TJK_EDO_AAA_515	58%	94%	0.153	0.931	0.16	0.26	-	-	0	0	100%	0.5
6TJK_EDO_AAA_509	55%	95%	0.149	0.916	0.2	0.19	-	-	0	0	100%	1
6TJK_EDO_BBB_1923	52%	98%	0.203	0.961	0.17	0.09	-	-	0	0	100%	1
6TJK_EDO_BBB_1901	50%	95%	0.106	0.853	0.11	0.28	-	-	0	0	100%	1
6TJK_EDO_BBB_1908	46%	49%	0.124	0.858	0.75	1.2	-	-	0	0	100%	1
6TJK_EDO_BBB_1918	45%	76%	0.136	0.866	0.29	0.66	-	-	1	0	100%	1
6TJK_EDO_AAA_511	44%	98%	0.118	0.845	0.12	0.13	-	-	0	0	100%	1
6TJK_EDO_AAA_510	40%	72%	0.151	0.861	0.52	0.57	-	-	0	0	100%	1
6TJK_EDO_BBB_1930	40%	98%	0.143	0.852	0.07	0.2	-	-	1	0	100%	1
6TJK_EDO_BBB_1906	38%	82%	0.146	0.848	0.29	0.51	-	-	1	0	100%	0.5
6TJK_EDO_AAA_521	35%	93%	0.154	0.842	0.2	0.28	-	-	0	0	100%	0.75
6TJK_EDO_AAA_504	35%	92%	0.158	0.843	0.19	0.34	-	-	0	0	100%	1
6TJK_EDO_BBB_1919	33%	77%	0.201	0.879	0.22	0.69	-	-	3	0	100%	1
6TJK_EDO_BBB_1907	32%	97%	0.22	0.895	0.14	0.18	-	-	0	0	100%	1
6TJK_EDO_AAA_517	32%	95%	0.147	0.819	0.2	0.19	-	-	4	0	100%	0.5
6TJK_EDO_AAA_513	31%	97%	0.209	0.877	0.09	0.21	-	-	0	0	100%	0.5
6TJK_EDO_BBB_1914	30%	85%	0.128	0.79	0.06	0.67	-	-	0	0	100%	1
6TJK_EDO_BBB_1912	21%	88%	0.13	0.734	0.23	0.43	-	-	0	0	100%	1
6TJK_EDO_AAA_514	19%	94%	0.17	0.766	0.24	0.21	-	-	0	0	100%	1
6TJK_EDO_BBB_1917	17%	95%	0.179	0.755	0.09	0.31	-	-	1	0	100%	1
6TJK_EDO_BBB_1929	15%	88%	0.265	0.827	0.35	0.33	-	-	0	0	100%	1
6TJK_EDO_AAA_527	11%	96%	0.244	0.764	0.13	0.23	-	-	0	0	100%	0.5
6TJK_EDO_BBB_1928	6%	100%	0.272	0.701	0.1	0.08	-	-	0	0	100%	0.5
8AX3_EDO_B_524	90%	97%	0.065	0.945	0.08	0.24	-	-	0	0	100%	1
6Q1N_EDO_A_611	85%	81%	0.078	0.942	0.46	0.37	-	-	0	0	100%	1
7NWV_EDO_AAA_620	79%	92%	0.108	0.953	0.37	0.15	-	-	0	0	100%	1
6YTR_EDO_BBB_2711	79%	97%	0.105	0.949	0.11	0.2	-	-	0	0	100%	1
6Z39_EDO_BBB_513	66%	100%	0.1	0.904	0.11	0.06	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.